supply chain

Sandy Salverson, PharmD, BCPS, VP Pharmacy Operations, OSF HealthCare System, Staci Hermann, PharmD, MS, Chief Pharmacy Officer, Dartmouth-Hitchcock Health, and James Stevenson, PharmD, FASHP, FFIP, VP Medication Systems Strategy, Omnicell.  Recently aggregated nationwide drug data from hundreds of health systems, as well as outpatient prescription data, show COVID-19 response and post-recovery have had dramatic impacts on medication availability, utilization...

Christopher R. Fortier, PharmD, FASHP, Chief Pharmacy Officer, Massachusetts General Hospital, Partners HealthCare (Mass General Brigham).  Healthcare providers are vulnerable to serious legal, financial, operational and reputational risks - and regulatory fines - due to employee drug diversion and inadequate internal controls. COVID-19 has increased employee’s feelings of stress and burnout has spiked to new levels. Furthermore, mounting evidence...

John Halamka, MD, President, Mayo Clinic Platform, and Brian Anderson, MD, Chief Digital Health Physician, The Mitre Corporation. Drs. Halamka and Anderson share the vision behind a private-industry led healthcare coalition combatting the COVID-19 pandemic. They discuss specific progress to date, identified best practices, particularly around critical COVID-19-related supply chain issues, and areas where coalition members are collaborating to deliver...